Abstract
The idea of using magnetic nanomaterials in biomedical applications has been studied since last decades. Magnetic nanomaterials have been found as a promising candidate in biological applications. This chapter presented the diverse approach to engineer the nanoparticles for targeted applications. Superparamagnetic iron oxide nanoparticle (SPION) cores of 10–25 nm were synthesised using co-precipitation method iron (II) and iron (III) salts in alkaline medium. The superparamagnetic behaviour is an ideal solid support for the hyperthermia ablation and magnetic field-triggered stimuli for drug release. These cores were further coated with mesoporous silica rendering them versatile materials, which can enhance the stability, drug-loading capacity and its release in controllable manner. Moreover, their promising applications as magnetic field-triggered hyperthermia ablation and magnetic field-triggered controlled-release drug delivery combining both thermos-chemotherapy system.
These materials were characterised using a variety of techniques such as Zetasizer, scanning electron microscopy (SEM), energy dispersive X-ray spectroscopy (EDAX), Fourier transform infrared spectroscopy (FTIR), Brunauer-Emmett-Teller (BET) analysis, transmission electron microscopy (TEM), X-ray diffraction (XRD), thermogravimetric analysis (TGA), vibrating sample magnetometer (VSM) and magnetic field-induced hyperthermia. The diameter of spherical superparamagnetic iron oxide nanoparticles was measured to be from 10 to 255 nm. Crystalline magnetite (Fe3O4) structures were confirmed by powder XRD. These magnetite nanocrystals were further modified with a biocompatible silica shell. Brunauer-Emmett-Teller (BET) analysis revealed a mesoporous shell structure. VSM of core-shell composite materials depicted superparamagnetic nature; hence, these materials have the ability to heat over the exposure to an applied external magnetic field for hyperthermia ablation.
Anticancer drug (doxorubicin, DOX) loading and release profile of bare spherical and silica-coated spheres were studied for potential therapeutic application. Exposure to AC magnetic field (200 G, 406 kHz), the SPION materials generated hyperthermia in a time-dependent manner reaching 50 °C in 3 min. Magnetic field-triggered drug release was seen only in spherical core-shell nanocomposites with 6X higher compared at 37 °C without exposure.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Bruce IJ, Taylor J, Todd M, Davies MJ, Borioni E, Sangregorio C, Sen T (2004) Synthesis, characterisation and application of silica-magnetite nanocomposites. J Magn Magn Mater 284:145–160
Mahmoudi M, Sant S, Wang B, Laurent S, Sen T (2011) Superparamagnetic iron oxide nanoparticles (SPIONs): development, surface modification and applications in chemotherapy. Adv Drug Deliv Rev 63(1–2):24–46
Sen T, Bruce IJ (2009) Mesoporous silica–magnetite Nanocomposites: fabrication, characterisation and applications in biosciences. Microporous Mesoporous Mater 120(3):246–251
Sen T, Sheppard SJ, Mercer T, Eizadi-sharifabad M, Mahmoudi M, Elhissi A (2012) Simple one-pot fabrication of ultra-stable core-shell superparamagnetic nanoparticles for potential application in drug delivery. RSC Adv 2(12):5221
Kirschvink JL, Kobayashi-Kirschvink A, Diaz-Ricci JC, Kirschvink SJ (1992) Magnetite in human tissues: a mechanism for the biological effects of weak ELF magnetic fields. Bioelectromagnetics 13(S1):101–113
Hergt R, Andra W, d’Ambly CG, Hilger I, Kaiser WA, Richter U, Schmidt H-G (1998) Physical limits of hyperthermia using magnetite fine particles. IEEE Trans Magn 34(5):3745–3754
Santhosh PB, Ulrih NP (2013) Multifunctional superparamagnetic iron oxide nanoparticles: promising tools in cancer theranostics. Cancer Lett 336(1):8–17
Maity D, Kale SN, Kaul-Ghanekar R, Xue J-M, Ding J (2009) Studies of magnetite nanoparticles synthesized by thermal decomposition of iron (III) acetylacetonate in tri (ethylene glycol). J Magn Magn Mater 321(19):3093–3098
Amara D, Felner I, Nowik I, Margel S (2009) Synthesis and characterization of Fe and Fe 3 O 4 nanoparticles by thermal decomposition of triiron dodecacarbonyl. Colloids Surf A Physicochem Eng Asp 339(1):106–110
Laurent S, Henoumont C, Stanicki D, Boutry S, Lipani E, Belaid S, Muller RN, Vander Elst L (2017) Superparamagnetic iron oxide nanoparticles. In: MRI contrast agents. Springer, Singapore, pp 55–109
Cai H, An X, Cui J, Li J, Wen S, Li K, Shen M, Zheng L, Zhang G, Shi X (2013) Facile hydrothermal synthesis and surface functionalization of polyethyleneimine-coated iron oxide nanoparticles for biomedical applications. ACS Appl Mater Interfaces 5(5):1722–1731
Guardia P, Di Corato R, Lartigue L, Wilhelm C, Espinosa A, Garcia-Hernandez M, Gazeau F, Manna L, Pellegrino T (2012) Water-soluble iron oxide nanocubes with high values of specific absorption rate for cancer cell hyperthermia treatment. ACS Nano 6(4):3080–3091
Nordmeyer D, Stumpf P, Gröger D, Hofmann A, Enders S, Riese SB, Dernedde J, Taupitz M, Rauch U, Haag R (2014) Iron oxide nanoparticles stabilized with dendritic polyglycerols as selective MRI contrast agents. Nanoscale 6(16):9646–9654
Rajabi F, Kakeshpour T, Saidi MR (2013) Supported iron oxide nanoparticles: recoverable and efficient catalyst for oxidative SS coupling of Thiols to disulfides. Catal Commun 40:13–17
Sakulkhu U, Mahmoudi M, Maurizi L, Salaklang J, Hofmann H (2014) Protein corona composition of superparamagnetic iron oxide nanoparticles with various physico-chemical properties and coatings. Sci Rep 4:5020
Yan X, Zhu P, Li J (2010) Self-assembly and application of diphenylalanine-based nanostructures. Chem Soc Rev 39(6):1877
Sharifabad ME, Hodgson B, Jellite M, Mercer T, Sen T (2014) Enzyme immobilised novel core-shell superparamagnetic nanocomposites for enantioselective formation of 4-(R)-hydroxycyclopent-2-en-1-(S)-acetate. Chem Commun 50(76):11185–11187
Sen T, Sebastianelli A, Bruce IJ (2006) Mesoporous silica−magnetite nanocomposite: fabrication and applications in magnetic bioseparations. J Am Chem Soc 128(22):7130–7131
Holzwarth U, Gibson N (2011) The Scherrer equation versus the’Debye-Scherrer equation. Nat Nanotechnol 6(9):534
Monshi A, Foroughi MR, Monshi MR (2012) Modified Scherrer equation to estimate more accurately nano-crystallite size using XRD. World J Nano Sci Eng 2(03):154
Burton AW, Ong K, Rea T, Chan IY (2009) On the estimation of average crystallite size of zeolites from the Scherrer equation: a critical evaluation of its application to zeolites with one-dimensional pore systems. Microporous Mesoporous Mater 117(1):75–90
El Mendili Y, Bardeau J-F, Randrianantoandro N, Greneche J-M, Grasset F (2016) Structural behavior of laser-irradiated γ-Fe2O3 nanocrystals dispersed in porous silica matrix : γ-Fe2O3 to α-Fe2O3 phase transition and formation of ε-Fe2O3. Sci Technol Adv Mater 17(1):597–609
Simeonidis K, Martinez-Boubeta C, Balcells L, Monty C, Stavropoulos G, Mitrakas M, Matsakidou A, Vourlias G, Angelakeris M (2013) Fe-based nanoparticles as tunable magnetic particle hyperthermia agents. J Appl Phys 114(10):103904
Jiles D (2015) Introduction to magnetism and magnetic materials. CRC Press
Harris LA (2002) Polymer stabilized magnetite nanoparticles and poly (propylene oxide) modified styrene-dimethacrylate networks.
Brown WF Jr (1963) Thermal fluctuations of a single-domain particle. Phys Rev 130(5):1677
Graczyk H, Bryan LC, Lewinski N, Suarez G, Coullerez G, Bowen P, Riediker M (2015) Physicochemical characterization of nebulized superparamagnetic iron oxide nanoparticles (SPIONs). J Aerosol Med Pulm Drug Deliv 28(1):43–51
Ling D, Lee N, Hyeon T (2015) Chemical synthesis and assembly of uniformly sized iron oxide nanoparticles for medical applications. Acc Chem Res 48(5):1276–1285
Karimzadeh I, Aghazadeh M, Ganjali MR, Norouzi P, Shirvani-Arani S, Doroudi T, Kolivand PH, Marashi SA, Gharailou D (2016) A novel method for preparation of bare and poly (vinylpyrrolidone) coated superparamagnetic iron oxide nanoparticles for biomedical applications. Mater Lett 179:5–8
Kandasamy G, Surendran S, Chakrabarty A, Kale SN, Maity D (2016) Facile synthesis of novel hydrophilic and carboxyl-amine functionalized superparamagnetic iron oxide nanoparticles for biomedical applications. RSC Adv 6(102):99948–99959
Feng B, Hong RY, Wang L, Guo L, Li HZ, Ding J, Zheng Y, Wei DG (2008) Synthesis of Fe 3 O 4/APTES/PEG diacid functionalized magnetic nanoparticles for MR imaging. Colloids Surf A Physicochem Eng Asp 328(1):52–59
Banaei A, Vojoudi H, Karimi S, Bahar S, Pourbasheer E (2015) Synthesis and characterization of new modified silica coated magnetite nanoparticles with bisaldehyde as selective adsorbents of Ag(i) from aqueous samples. RSC Adv 5(101):83304–83313
Greene D, Serrano-Garcia R, Govan J, Gun’ko YK (2014) Synthesis characterization and photocatalytic studies of cobalt ferrite-silica-titania nanocomposites. Nanomaterials 4(2):331–343
Qu L, Tie S (2009) Mesoporous silica-coated superparamagnetic magnetite functionalized with CuO and its application as a desulfurizer. Microporous Mesoporous Mater 117(1):402–405
Chatterjee J, Haik Y, Chen C-J (2003) Size dependent magnetic properties of iron oxide nanoparticles. J Magn Magn Mater 257(1):113–118
Maaz K, Duan JL, Karim S, Chen YH, Zhai PF, Xu LJ, Yao HJ, Liu J (2016) Fabrication and size dependent magnetic studies of Ni X Mn 1− X Fe 2 O 4 (X= 0.2) cubic nanoplates. J Alloys Compd 684:656–662
Knežević NŽ, Lin VS-Y (2013) A magnetic mesoporous silica nanoparticle-based drug delivery system for photosensitive cooperative treatment of cancer with a mesopore-capping agent and mesopore-loaded drug. Nanoscale 5(4):1544–1551
Wang YD, Zhang S, Ma CL, Li HD (2007) Synthesis and room temperature photoluminescence of ZnO/CTAB ordered layered nanocomposite with flake-like architecture. JOL 126(2):661–664
Bordbar AK, Rastegari AA, Amiri R, Ranjbakhsh E, Abbasi M, Khosropour AR (2014) Characterization of modified magnetite nanoparticles for albumin immobilization. Biotechnol Res Int 2014:705068
Nikam DS, Jadhav SV, Khot VM, Phadatare MR, Pawar SH (2014) Study of AC magnetic heating characteristics of co 0.5 Zn 0.5 Fe 2 O 4 nanoparticles for magnetic hyperthermia therapy. J Magn Magn Mater 349:208–213
Majeed J, Pradhan L, Ningthoujam RS, Vatsa RK, Bahadur D, Tyagi AK (2014) Enhanced specific absorption rate in silanol functionalized Fe 3 O 4 CORE–shell nanoparticles: study of Fe leaching in Fe 3 O 4 and hyperthermia in L929 and HeLa cells. Colloids Surf B Biointerfaces 122:396–403
Cihoric N, Tsikkinis A, van Rhoon G, Crezee H, Aebersold DM, Bodis S, Beck M, Nadobny J, Budach V, Wust P (2015) Hyperthermia-related clinical trials on cancer treatment within the ClinicalTrials. Gov registry. Int J Hyperthermia 31(6):609–614
Kampinga HH (2006) Cell biological effects of hyperthermia alone or combined with radiation or drugs: a short introduction to newcomers in the field. Int J Hyperthermia 22(3):191–196
Lepock JR (2004) Role of nuclear protein denaturation and aggregation in thermal radiosensitization. Int J Hyperthermia 20(2):115–130
Nishita M, Inoue S, Tsuda M, Tateda C, Miyashita T (1998) Nuclear translocation and increased expression of Bax and disturbance in cell cycle progression without prominent apoptosis induced by hyperthermia. Exp Cell Res 244(1):357–366
Kampinga HH, Dikomey E (2001) Hyperthermic radiosensitization: mode of action and clinical relevance. Int J Radiat Biol 77(4):399–408
Shen R-N, Lu L, Young P, Shidnia H, Hornback NB, Broxmeyer HE (1994) Influence of elevated temperature on natural killer cell activity, lymphokine-activated killer cell activity and lectin-dependent cytotoxicity of human umbilical cord blood and adult blood cells. Int J Radiat Oncol Biol Phys 29(4):821–826
Burd R, Dziedzic TS, Xu Y, Caligiuri MA, Subjeck JR, Repasky EA (1998) Tumor cell apoptosis, lymphocyte recruitment and tumor vascular changes are induced by low temperature, long duration (fever-like) whole body hyperthermia. J Cell Physiol 177(1):137–147
Pettigrew RT, Galt JM, Ludgate CM, Smith AN (1974) Clinical effects of whole-body hyperthermia in advanced malignancy. Br Med J 4(5946):679–682
Paulides MM, Stauffer PR, Neufeld E, Maccarini PF, Kyriakou A, Canters RAM, Diederich CJ, Bakker JF, Van Rhoon GC (2013) Simulation techniques in hyperthermia treatment planning. Int J Hyperthermia 29(4):346–357
Varon J, Acosta P (2008) Therapeutic hypothermia: past, present, and future. Chest J 133(5):1267–1274
Vaupel P, Kallinowski F, Okunieff P (1989) Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: a review. Cancer Res 49(23):6449–6465
Wust P, Hildebrandt B, Sreenivasa G, Rau B, Gellermann J, Riess H, Felix R, Schlag PM (2002) Hyperthermia in combined treatment of cancer. Lancet Oncol 3(8):487–497
Lele PP (1990) Electronically-controlled variable focus ultrasound hyperthermia system.
Jordan A, Scholz R, Wust P, Fähling H, Felix R (1999) Magnetic fluid hyperthermia (MFH): cancer treatment with AC magnetic field induced excitation of biocompatible superparamagnetic nanoparticles. J Magn Magn Mater 201(1):413–419
Mornet S, Vasseur S, Grasset F, Duguet E (2004) Magnetic nanoparticle design for medical diagnosis and therapy. J Mater Chem 14(14):2161–2175
Ang KL, Venkatraman S, Ramanujan RV (2007) Magnetic PNIPA hydrogels for hyperthermia applications in cancer therapy. Mater Sci Eng C 27(3):347–351
INL (2017) International Iberian Nanotechnology.
Hahn GM (1974) Metabolic aspects of the role of hyperthermia in mammalian cell inactivation and their possible relevance to cancer treatment. Cancer Res 34(11):3117–3123
Quinto CA, Mohindra P, Tong S, Bao G (2015) Multifunctional superparamagnetic iron oxide nanoparticles for combined chemotherapy and hyperthermia cancer treatment. Nanoscale 7(29):12728–12736
Shevtsov M, Multhoff G (2016) Recent developments of magnetic nanoparticles for theranostics of brain tumor. Curr Drug Metab 17(8):737–744
Cavaliere R, Giogatto BC, Giovanella BC (1967) Selective heat sensitivity of cancer cells. Cancer 20(9):1351–1381
Sellins KS, Cohen JJ (1991) Hyperthermia induces apoptosis in thymocytes. Radiat Res 126(1):88–95
Paolini A, Guarch CP, Ramos-López D, Lapuente J, Lascialfari A, Guari Y, Larionova J, Long J, Nano R (2016) Rhamnose-coated superparamagnetic iron-oxide nanoparticles: an evaluation of their in vitro cytotoxicity, genotoxicity and carcinogenicity. J Appl Toxicol 36(4):510–520
Wong RSL, Kapp LN, Krishnaswamy G, Dewey WC (1993) Critical steps for induction of chromosomal aberrations in CHO cells heated in S phase. Radiat Res 133(1):52–59
Stahl H, Wust P, Maier-Hauff K, Seebass M, Mischel M, Gremmler M, Golde G, Löffel J, Felix R (1995) The use of an early postoperative interstitial-hyperthermia combination therapy in malignant gliomas. Strahlentherapie und Onkol. Organ der Dtsch. Rontgengesellschaft...[et al] 171(9):510–524
Sneed PK, Stauffer PR, McDermott MW, Diederich CJ, Lamborn KR, Prados MD, Chang S, Weaver KA, Spry L, Malec MK (1998) Survival benefit of hyperthermia in a prospective randomized trial of brachytherapy boost±hyperthermia for glioblastoma multiforme. Int J Radiat Oncol Biol Phys 40(2):287–295
Mitsumori M, Hiraoka M, Okuno Y, Nishimura Y, Li YP, Fujishiro S, Nagata Y, Abe M, Koishi M, Sano T (1996) A phase I and II clinical trial of a newly developed ultrasound hyperthermia system with an improved planar transducer. Int J Radiat Oncol Biol Phys 36(5):1169–1175
Wismeth C, Dudel C, Pascher C, Ramm P, Pietsch T, Hirschmann B, Reinert C, Proescholdt M, Rümmele P, Schuierer G (2010) Transcranial electro-hyperthermia combined with alkylating chemotherapy in patients with relapsed high-grade gliomas: phase I clinical results. J Neurooncol 98(3):395–405
Gilchrist RK, Medal R, Shorey WD, Hanselman RC, Parrott JC, Taylor CB (1957) Selective inductive heating of lymph nodes. Ann Surg 146(4):596
Hoopes PJ, Petryk AA, Misra A, Kastner EJ, Pearce JA, Ryan TP (2015) Utility and translatability of mathematical modeling, cell culture and small and large animal models in magnetic nanoparticle hyperthermia cancer treatment research. SPIE BiOS, International Society for Optics and Photodermatol, p. 932604
Thiesen B, Jordan A (2008) Clinical applications of magnetic nanoparticles for hyperthermia. Int J Hyperthermia 24(6):467–474
Attaluri A, Kandala SK, Wabler M, Zhou H, Cornejo C, Armour M, Hedayati M, Zhang Y, DeWeese TL, Herman C (2015) Magnetic nanoparticle hyperthermia enhances radiation therapy: a study in mouse models of human prostate cancer. Int J Hyperthermia 31(4):359–374
Kashevsky BE, Kashevsky SB, Korenkov VS, Istomin YP, Terpinskaya TI, Ulashchik VS (2015) Magnetic hyperthermia with hard-magnetic nanoparticles. J Magn Magn Mater 380:335–340
Tang Y, Flesch RCC, Jin T (2017) A method for increasing the homogeneity of the temperature distribution during magnetic fluid hyperthermia with a Fe-Cr-Nb-B alloy in the presence of blood vessels. J Magn Magn Mater 432:330–335
Hervault A, Thanh NTK (2014) Magnetic nanoparticle-based therapeutic agents for thermo-chemotherapy treatment of cancer. Nanoscale 6(20):11553–11573
Jordan A, Scholz R, Wust P, Fähling H, Krause J, Wlodarczyk W, Sander B, Vogl T, Felix R (1997) Effects of magnetic fluid hyperthermia (MFH) on C3H mammary carcinoma in vivo. Int J Hyperthermia 13(6):587–605
Schmid G (2011) Nanoparticles: from theory to application. Wiley, Somerset
Maier-Hauff K, Ulrich F, Nestler D, Niehoff H, Wust P, Thiesen B, Orawa H, Budach V, Jordan A (2011) Efficacy and safety of intratumoral thermotherapy using magnetic iron-oxide nanoparticles combined with external beam radiotherapy on patients with recurrent glioblastoma multiforme. J Neurooncol 103(2):317–324
Frimpong RA, Dou J, Pechan M, Hilt JZ (2010) Enhancing remote controlled heating characteristics in hydrophilic magnetite nanoparticles via facile co-precipitation. J Magn Magn Mater 322(3):326–331
Ghosh R, Pradhan L, Devi YP, Meena SS, Tewari R, Kumar A, Sharma S, Gajbhiye NS, Vatsa RK, Pandey BN, Ningthoujam RS (2011) Induction heating studies of Fe3O4 magnetic nanoparticles capped with oleic acid and polyethylene glycol for hyperthermia. J Mater Chem 21(35):13388–13398
Ma M, Wu Y, Zhou J, Sun Y, Zhang Y, Gu N (2004) Size dependence of specific power absorption of Fe 3 O 4 particles in AC magnetic field. J Magn Magn Mater 268(1):33–39
Zhang L-Y, Gu H-C, Wang X-M (2007) Magnetite ferrofluid with high specific absorption rate for application in hyperthermia. J Magn Magn Mater 311(1):228–233
Müller R, Hergt R, Zeisberger M, Gawalek W (2005) Preparation of magnetic nanoparticles with large specific loss power for heating applications. J Magn Magn Mater 289:13–16
Behdadfar B, Kermanpur A, Sadeghi-Aliabadi H, del Puerto Morales M, Mozaffari M (2012) Synthesis of high intrinsic loss power aqueous ferrofluids of iron oxide nanoparticles by citric acid-assisted hydrothermal-reduction route. J Solid State Chem 187:20–26
Surendra MK, Dutta R, Ramachandra Rao MS (2014) Realization of highest specific absorption rate near superparamagnetic limit of CoFe 2 O 4 colloids for magnetic hyperthermia applications. Mater Res Express 1(2):26107
Thorat ND, Khot VM, Salunkhe AB, Prasad AI, Ningthoujam RS, Pawar SH (2013) Surface functionalized LSMO nanoparticles with improved colloidal stability for hyperthermia applications. J Phys D Appl Phys 46(10):105003
Pankhurst QA, Connolly J, Jones SK, Dobson J (2003) Applications of magnetic nanoparticles in biomedicine. J Phys D Appl Phys 36(13):R167
Huang S, Wang S-Y, Gupta A, Borca-Tasciuc D-A, Salon SJ (2012) On the measurement technique for specific absorption rate of nanoparticles in an alternating electromagnetic field. Meas Sci Technol 23(3):35701
Bi H, Ma S, Li Q, Han X (2016) Magnetically triggered drug release from biocompatible microcapsules for potential cancer therapeutics. J Mater Chem B 4(19):3269–3277
Sanson C, Diou O, Thevenot J, Ibarboure E, Soum A, Brûlet A, Miraux S, Thiaudière E, Tan S, Brisson A (2011) Doxorubicin loaded magnetic polymersomes: theranostic nanocarriers for MR imaging and magneto-chemotherapy. ACS Nano 5(2):1122–1140
Thévenot J, Oliveira H, Sandre O, Lecommandoux S (2013) Magnetic responsive polymer composite materials. Chem Soc Rev 42(17):7099–7116
Saint-Cricq P, Deshayes S, Zink JI, Kasko AM (2015) Magnetic field activated drug delivery using thermodegradable Azo-functionalised PEG-coated core–shell mesoporous silica nanoparticles. Nanoscale 7(31):13168–13172
Oliveira H, Pérez-Andrés E, Thevenot J, Sandre O, Berra E, Lecommandoux S (2013) Magnetic field triggered drug release from polymersomes for cancer therapeutics. J Control Release 169(3):165–170
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG
About this chapter
Cite this chapter
Majid, A., Ahmed, W., Patil-Sen, Y., Sen, T. (2018). Synthesis and Characterisation of Magnetic Nanoparticles in Medicine. In: Jackson, M., Ahmed, W. (eds) Micro and Nanomanufacturing Volume II. Springer, Cham. https://doi.org/10.1007/978-3-319-67132-1_14
Download citation
DOI: https://doi.org/10.1007/978-3-319-67132-1_14
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-67130-7
Online ISBN: 978-3-319-67132-1
eBook Packages: EngineeringEngineering (R0)